Synovial Sarcoma clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
Phase 2 CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma
open to eligible people ages 12 years and up
The objective of this study is to assess safety and efficacy of CAB-AXL-ADC in solid tumors
Our lead scientists for Synovial Sarcoma research studies include Brian Schulte, MD.